Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy

Bryan W. Miller(Cancer Research UK Scotland Institute), Owen J. Sansom(Cancer Research UK)
EMBO Molecular Medicine
June 15, 2015
Cited by 263


Related Papers